I
INIT
vs
O
OMX Stockholm 30
I
INIT
O
OMX Stockholm 30
Over the past 12 months, INIT has underperformed OMX Stockholm 30, delivering a return of -59% compared to the OMX Stockholm 30's +17% growth.
Stocks Performance
INIT vs OMX Stockholm 30
INIT vs OMX Stockholm 30
Performance Gap
INIT vs OMX Stockholm 30
INIT vs OMX Stockholm 30
Performance By Year
INIT vs OMX Stockholm 30
INIT vs OMX Stockholm 30
Loading
No Stocks Selected
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Initiator Pharma A/S
Glance View
Initiator Pharma A/S is a clinical-stage biotechnology company, which engages in the development of novel therapeutics within the field of mono-amine reuptake transporters targeting central nervous system (CNS)-disorders. The firm focuses on developing drugs for treatment of erectile dysfunction.
INIT
Intrinsic Value
8.24
SEK
Undervaluation 65%
I
